Erythropoietin treatment (EPO) reduced body weight and HOMA-IR (index of insulin resistance), and reduced white fat accumulation in high-fat diet (HFD)-induced obese mice in our study (Table 1, Figs 1A and 2A). This evidence concerns the gene EPO and Insulin resistance.